The January 2012 issue of the Journal of Drugs in Dermatology contains an article, written by Drs. Schweiger and Bernstein, which is the first case study of eyebrow growth from the topical use of bimatoprost.

Latisse (bimatoprost) is a topical medication that is FDA-approved for eyelash growth. Some physicians have used the medication for “off-label” use, such as use with eyelashes and scalp hair. However, until recently, there had not been any published medical literature describing the off-label use.

Castle Connolly has published the 11th edition of America’s Top Doctors. Dr. Bernstein is, once again, included on the peer-nominated list of doctors for his pioneering work in hair restoration.

The list represents just the top 1% of medical specialists in America. Dr. Bernstein is the first hair restoration physician to be named to this list for more than 10 consecutive years.

The New York Times, once again, has recognized Dr. Bernstein’s pioneering hair restoration techniques. The NYT Fashion and Style section noted that he is, “the first hair transplant surgeon on the east coast,” to use the ARTAS robotic system for Follicular Unit Extraction.

Dr. Bernstein’s pioneering work in developing FUT and FUE hair transplant procedures has influenced hair restoration physicians across the globe. Recently, his use of the ARTAS System for robotic FUE has grabbed international attention, as he was featured in a Japanese magazine.

From hair extensions to eyelash enhancement, our resident expert on hair loss in women is on the case. Dr. Eric Schweiger was featured in a segment on Good Morning America where he discussed the enhancement of eyelashes, which he called, “a universal sign of beauty.”